Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age16-35
SponsorInstitute of HIV Research and Innovation Foundation, Thailand

About this trial

CLYMAX is a two-phase observational study that assess multiple aspects of chemsex and young men who have sex with men (YMSM).

Phase I of the study (CLYMAX,IRB No. 0695/65) was a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) assessing multiple aspects of chemsex, including the patterns of chemsex use and the perspectives on factors influencing chemsex initiation/discontinuation, effects on physical health, mental health and social outcomes, and the necessary services for a comprehensive chemsex clinic among YMSM; and the acceptability and feasibility of developing a comprehensive chemsex clinic from the perspective of YMSM, their family members or peers, and clinic staff.

This phase II study (CLYMAX-2) will be a prospective cohort study using a quantitative data collection exploring the effectiveness of the implementation strategy of harm reduction models and consist of a larger number of YMSM, important baseline and follow-up information on multiple aspects of physical, psychological, and social harms.

Eligibility criteria

Qualifiers

Men who have sex with men

Aged 16-35 years

Current chemsex users (defined as last chemsex used within 3 months)

Able to read and communicate in Thai

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Group1

Treatment groups

No treatment groups listed

Sponsors and collaborators

Institute of HIV Research and Innovation Foundation, Thailand

Lead sponsor

The US NIH through the International Epidemiology Databases to Evaluate AIDS (IeDEA) IeDEA Asia-Pacific

Collaborator

amfAR, The Foundation for AIDS Research

Collaborator